BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 27191665)

  • 1. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C; Groh M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Moosig F; Holle J
    Z Rheumatol; 2019 May; 78(4):333-338. PubMed ID: 30627842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab.
    Tsioulos G; Kounatidis D; Vallianou NG; Koufopoulos N; Katsimbri P; Antoniadou A
    Am J Med Sci; 2023 Jan; 365(1):93-98. PubMed ID: 35970248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates for the treatment of EGPA.
    Raffray L; Guillevin L
    Presse Med; 2020 Oct; 49(3):104036. PubMed ID: 32652104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis.
    Pagnoux C; Berti A
    Expert Opin Pharmacother; 2023; 24(11):1269-1281. PubMed ID: 37204027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Therapies for ANCA-associated Vasculitis.
    Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
    Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
    Navarro-Mendoza EP; Tobón GJ
    Curr Rheumatol Rep; 2018 Apr; 20(5):23. PubMed ID: 29611001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
    Hellmich B; Holle J; Moosig F
    Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on eosinophilic granulomatosis with polyangiitis.
    Furuta S; Iwamoto T; Nakajima H
    Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
    Raffray L; Guillevin L
    Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
    Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
    Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ANCA-associated vasculitis].
    Krasselt ML; Holle JU
    Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
    Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
    Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
    Groh M; Pagnoux C; Baldini C; Bel E; Bottero P; Cottin V; Dalhoff K; Dunogué B; Gross W; Holle J; Humbert M; Jayne D; Jennette JC; Lazor R; Mahr A; Merkel PA; Mouthon L; Sinico RA; Specks U; Vaglio A; Wechsler ME; Cordier JF; Guillevin L
    Eur J Intern Med; 2015 Sep; 26(7):545-53. PubMed ID: 25971154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome).
    Mouthon L; Dunogue B; Guillevin L
    J Autoimmun; 2014; 48-49():99-103. PubMed ID: 24530234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Jerrentrup A; Müller T; Mariss J; Dylla S
    Internist (Berl); 2018 May; 59(5):497-504. PubMed ID: 28983650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mepolizumab: Therapeutic strategy for a pediatric patient with eosinophilic granulomatosis with polyangiitis.
    Ozola L; Aleksejeva E; Stoldere D; Dāvidsone Z; Šantere R; Grantiņa I; Cīrule I; Krams A
    Pediatr Pulmonol; 2023 Mar; 58(3):973-979. PubMed ID: 36404638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.